90 related articles for article (PubMed ID: 15605596)
21. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
22. Drug release characteristics from nanoclay hybrids and their dispersions in organic polymers.
Ha JU; Xanthos M
Int J Pharm; 2011 Jul; 414(1-2):321-31. PubMed ID: 21601624
[TBL] [Abstract][Full Text] [Related]
23. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
24. Design of prolonged release tablets using new solid acrylic excipients for direct compression.
Villanova JC; Ayres E; Oréfice RL
Eur J Pharm Biopharm; 2011 Nov; 79(3):664-73. PubMed ID: 21827852
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo evaluation of tegaserod maleate pH-dependent tablets.
Zhang SQ; Thumma S; Chen GH; Deng WB; Repka MA; Li SM
Eur J Pharm Biopharm; 2008 May; 69(1):247-54. PubMed ID: 18037278
[TBL] [Abstract][Full Text] [Related]
26. Floating hot-melt extruded tablets for gastroretentive controlled drug release system.
Fukuda M; Peppas NA; McGinity JW
J Control Release; 2006 Oct; 115(2):121-9. PubMed ID: 16959356
[TBL] [Abstract][Full Text] [Related]
27. Development and evaluation of a time-specific pulsatile-release tablet of aceclofenac: a solution for morning pain in rheumatoid arthritis.
Qureshi J; Ahuja A; Baboota S; Chutani K; Jain S; Ali J
Methods Find Exp Clin Pharmacol; 2009; 31(1):15-23. PubMed ID: 19357794
[TBL] [Abstract][Full Text] [Related]
28. Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia.
Cha KH; Park J; Cho W; Gu DG; Jeong K; Hwang SJ
Arch Pharm Res; 2009 Nov; 32(11):1593-8. PubMed ID: 20091273
[TBL] [Abstract][Full Text] [Related]
29. Tracking of the physical ageing of amorphous pharmaceutical polymeric excipients by positron annihilation spectroscopy.
Zelkó R; Orbán A; Süvegh K
J Pharm Biomed Anal; 2006 Feb; 40(2):249-54. PubMed ID: 16143484
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous release of diclofenac sodium and papaverine hydrochloride from tablets and pellets using the flow-through cell apparatus described by dimensionless equations.
Kasperek R
Acta Pol Pharm; 2011; 68(2):261-72. PubMed ID: 21485300
[TBL] [Abstract][Full Text] [Related]
31. Melt extrusion bioadhesive delivery of diclofenac sodium granules using theobroma oil.
Attama AA; Adikwu MU
Boll Chim Farm; 2004 May; 143(4):174-7. PubMed ID: 15255341
[TBL] [Abstract][Full Text] [Related]
32. Citric acid monohydrate as a release-modifying agent in melt extruded matrix tablets.
Schilling SU; Bruce CD; Shah NH; Malick AW; McGinity JW
Int J Pharm; 2008 Sep; 361(1-2):158-68. PubMed ID: 18582547
[TBL] [Abstract][Full Text] [Related]
33. Development of a single unit extended release formulation for ZK 811 752, a weakly basic drug.
Kranz H; Guthmann C; Wagner T; Lipp R; Reinhard J
Eur J Pharm Sci; 2005 Sep; 26(1):47-53. PubMed ID: 15953712
[TBL] [Abstract][Full Text] [Related]
34. Investigating the Use of Polymeric Binders in Twin Screw Melt Granulation Process for Improving Compactibility of Drugs.
Batra A; Desai D; Serajuddin ATM
J Pharm Sci; 2017 Jan; 106(1):140-150. PubMed ID: 27578544
[TBL] [Abstract][Full Text] [Related]
35. Diclofenac sodium releasing pH-sensitive monolithic devices.
Basan H; Gümüşderelíoğlu M; Orbey T
Int J Pharm; 2002 Oct; 245(1-2):191-98. PubMed ID: 12270255
[TBL] [Abstract][Full Text] [Related]
36. In vitro dissolution studies of sodium diclofenac granules coated with Eudragit L-30D-55 by fluidized-bed system.
Silva OS; Souza CR; Oliveira WP; Rocha SC
Drug Dev Ind Pharm; 2006 Jul; 32(6):661-7. PubMed ID: 16885121
[TBL] [Abstract][Full Text] [Related]
37. Controlled release camptothecin tablets based on pluronic and poly(acrylic acid) copolymer. Effect of fabrication technique on drug stability, tablet structure, and release mode.
Bromberg L; Hatton TA; Barreiro-Iglesias R; Alvarez-Lorenzo C; Concheiro A
Drug Dev Ind Pharm; 2007 Jun; 33(6):607-15. PubMed ID: 17613025
[TBL] [Abstract][Full Text] [Related]
38. Formulation variables affecting drug release from xanthan gum matrices at laboratory scale and pilot scale.
Billa N; Yuen KH
AAPS PharmSciTech; 2000 Oct; 1(4):E30. PubMed ID: 14727895
[TBL] [Abstract][Full Text] [Related]
39. In vitro release of sodium diclofenac from a central core matrix tablet aimed for colonic drug delivery.
González-Rodríguez ML; Maestrelli F; Mura P; Rabasco AM
Eur J Pharm Sci; 2003 Sep; 20(1):125-31. PubMed ID: 13678801
[TBL] [Abstract][Full Text] [Related]
40. Effects of material properties and speed of compression on microbial survival and tensile strength in diclofenac tablet formulations.
Ayorinde JO; Itiola OA; Odeniyi MA
Arch Pharm Res; 2013 Mar; 36(3):273-81. PubMed ID: 23471558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
